In AF, Women Have A Bigger Risk Of Stroke Than Men
9 May 2012, 8:04 am
When compared to elderly men with atrial fibrillation, elderly women with AF have a significantly elevated risk for stroke. This increased risk occurs regardless of warfarin use, according to a new study published in JAMA.

antithrombotic/Anticoagulant Drugs: World Market 2012-2022
9 May 2012, 6:28 am
NEW YORK, May 9, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: antithrombotic/Anticoagulant Drugs: World Market 2012-2022 http://www.reportlinker.com/p0325493/antithrombotic/Anticoagulant-Drugs-World-Market-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationReport ...

Current anticoagulant therapy to prevent stroke might not be sufficient for older women with AF
9 May 2012, 2:18 am
In a study that examined use of the anticoagulant medication warfarin and risk of stroke following a diagnosis of atrial fibrillation in older patients, women, especially those 75 years or older, had a higher risk of stroke than men, regardless of their risk profile and use of warfarin, suggesting that current anticoagulant therapy to prevent stroke might not be sufficient for older women ...

Risk of stroke greater for women than men among older patients diagnosed with atrial fibrillation
8 May 2012, 3:55 pm
In a study that examined use of the anticoagulant medication warfarin and risk of stroke following a diagnosis of atrial fibrillation in older patients, women, especially those 75 years or older, had a higher risk of stroke than men, regardless of their risk profile and use of warfarin, suggesting that current anticoagulant therapy to prevent stroke might not be sufficient for older women ...

JCI early table of contents for May 8, 2012
8 May 2012, 11:49 am
( Journal of Clinical Investigation ) This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, May 8, 2012, in the JCI.

ADVENTRX Reports First Quarter 2012 Financial Results
7 May 2012, 7:00 am
SAN DIEGO, May 7, 2012 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (ANX) today reported financial results for the first quarter ended March 31, 2012."In the first quarter, we focused ...

Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial ...
3 May 2012, 7:07 am
RIDGEFIELD, Conn., May 3, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced the launch of the GLORIA™-AF Registry Program, the largest prospective observational study in non-valvular atrial fibrillation (NVAF) planned at this time. With a...

AstraZeneca and The Medicines Company Announce Global Collaboration in Acute Ischemic Heart Disease
25 April 2012, 11:31 am
AstraZeneca  and The Medicines Company announced today a global collaboration for acute ischemic heart disease compounds. The first part of this collaboration is a US co-promotion for AstraZeneca’s oral antiplatelet medicine BRILINTA® tablets.

BUSINESS WIRE: GLORIATM-AF Registry Program investigating use of antithrombotic therapy in 56,000 patients with atrial ...
20 April 2012, 2:10 am
MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.

GLORIATM-AF Registry Program investigating use of antithrombotic therapy in 56,000 patients with atrial fibrillation ...
20 April 2012, 2:07 am
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Boehringer Ingelheim announced today the launch of the GLORIATM-AF Registry Program, which is set to become the largest worldwide registry with the aim of understanding the long-term use of oral antithrombotic therapy in the prevention of non-valvular atrial fibrillation (AF)-related stroke in a real-world setting. With up to 56,000 patients planned ...